Furthermore, the decrease in phosphomevalonate kinase could be harnessed for alerting the immune system to the pathways that guard the cancers from being attacked because the mevalonate pathway is pivotal to cancer immune surveillance [25]. The gene discussed is PMVK; the disease is cancer.